Get to know our clinical trials

Clinical trial of multiple treatment combinations in patients with melanoma (morpheus-melanoma).

THE GOAL OF THIS STUDY IS TO COMPARE THE EFFECTS, GOOD OR BAD, THAT ITA TREATMENTS OR TREATMENT COMBINATIONS HAVE ON YOU AND YOUR SKIN CANCER, IN ORDER TO KNOW WHICH TREATMENT IS BETTER

Status
In recruitment
headquarters
Madrid

Technical Summary

  • PHASE IB/II, OPEN-LABEL, MULTICENTER, RANDOMIZED, OPEN-LABEL UMBRELLA STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MULTIPLE TREATMENT COMBINATIONS IN PATIENTS WITH MELANOMA (MORPHEUS-MELANOMA). IMMUNOTHERAPY
  • Code EudraCT: 2021-002147-29
  • Protocol number: BO43328
  • Promoter: Hoffman La Roche
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.